Examkin

Question

Difficulty: HardEndocrine and Metabolic Mechanisms

Match the following classic endocrine diagnostic testing profiles with their precise underlying pathophysiologic and molecular mechanisms.

  • Elevated baseline ACTH; failure of cortisol suppression with low-dose dexamethasone, but successful suppression with high-dose dexamethasone.Autonomous hormone secretion by a pituitary adenoma that retains a shifted set-point for glucocorticoid receptor-mediated negative feedback.
  • Markedly elevated baseline ACTH; failure of cortisol suppression with both low-dose and high-dose dexamethasone.Unregulated paraneoplastic polypeptide hormone production that completely lacks physiologic negative feedback inhibition.
  • Elevated aldosterone-to-renin ratio; failure of serum aldosterone to suppress following a 2-liter intravenous saline load.Autonomous zona glomerulosa hypersecretion, frequently driven by somatic mutations in the KCNJ5 potassium channel.
  • Normal baseline 17-hydroxyprogesterone; exaggerated elevation of 17-hydroxyprogesterone following intravenous cosyntropin administration.Partial impairment of the adrenal microsomal cytochrome P450 enzyme responsible for converting 17-hydroxyprogesterone to 11-deoxycortisol.

Answer

The diagnostic profiles pair accurately as follows: High-dose dexamethasone suppression matches with the shifted set-point of pituitary adenomas; complete failure to suppress matches with unregulated paraneoplastic (ectopic) ACTH production; aldosterone non-suppression matches with autonomous zona glomerulosa hypersecretion (KCNJ5 mutations); and the exaggerated cosyntropin response matches with partial cytochrome P450 (21-hydroxylase) impairment.
Each testing profile accurately reflects a distinct underlying cellular and molecular defect. The dynamic response of an endocrine axis to pharmacologic provocation (dexamethasone, saline, or cosyntropin) directly tests the integrity of specific receptor-mediated feedback loops and enzymatic pathways.

Step-by-Step Solution

1
Analyze the first diagnostic profile involving low-dose suppression failure but high-dose success.
Identifies Cushing disease (pituitary adenoma).
Pituitary corticotroph adenomas retain a functional but shifted set-point for glucocorticoid negative feedback.
2
Analyze the second diagnostic profile involving complete suppression failure at high dexamethasone doses.
Identifies ectopic ACTH syndrome.
Paraneoplastic tumors producing ACTH do not express glucocorticoid receptors and therefore completely lack negative feedback.
3
Analyze the third diagnostic profile involving failure to suppress aldosterone with intravenous saline.
Identifies primary hyperaldosteronism (Conn syndrome).
Volume expansion normally suppresses renin and subsequent aldosterone production; failure to suppress indicates an autonomous adrenal source, commonly linked to KCNJ5 somatic mutations.
4
Analyze the fourth diagnostic profile involving an exaggerated 17-OHP response to cosyntropin.
Identifies non-classic congenital adrenal hyperplasia.
A partial defect in 21-hydroxylase (CYP21A2) limits the conversion of 17-OHP to 11-deoxycortisol. Provocation with synthetic ACTH (cosyntropin) rapidly unmasks this bottleneck, resulting in an exaggerated buildup of 17-OHP.

Key Concept

Integration of endocrine dynamic testing with the underlying molecular and pathophysiologic mechanisms of adrenal and pituitary disorders.
Rate this question

Topics

Endocrine and Metabolic Mechanisms

More questions from this topic